[Roles of microvesicles in tumor progress and its clinical application]

Ying-ying Wu1, Xiu-jin Ye

  • 1Center of Bone Marrow Ttransplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

Insights

Tumor-derived membrane microvesicles (TMVs) mediate intercellular communication, influencing tumor progression, metastasis, and immune evasion. TMVs also hold potential for cancer vaccines and biomarkers, though purification requires improvement.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Immunology

Context:

  • Microvesicles facilitate intercellular communication via transported molecules.
  • Tumor-derived membrane microvesicles (TMVs) significantly impact tumor progression and microenvironment.
  • TMVs play roles in angiogenesis, metastasis, and immune system modulation.

Purpose:

  • To review the multifaceted roles of TMVs in cancer.
  • To highlight TMVs' potential in cancer diagnostics and therapeutics.
  • To identify challenges in TMV research, particularly purification.

Summary:

  • TMVs transport proteins, microRNA, and DNA, altering recipient cell phenotypes and promoting tumor growth.
  • They contribute to metastasis by degrading the extracellular matrix and facilitate immune evasion.
  • TMVs also serve as a source of tumor antigens for vaccine development and circulating biomarkers for cancer detection.

Impact:

  • Understanding TMVs can lead to novel cancer diagnostic and prognostic tools.
  • TMVs offer potential therapeutic strategies, including cancer vaccines.
  • Improved TMV purification methods are crucial for advancing their clinical applications.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...